• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ThromboGenics NV

+ Add to Watchlist

THR:BB

7.4700 EUR 0.4960 7.11%

As of 06:57:52 ET on 10/21/2014.

Company Profile for ThromboGenics NV (THR)

ThromboGenics NV is a biopharmaceutical company focused on the development of therapeutics for conditions related to the vascular system. The Company is focused on developing medicines to treat visual disorders, cardiovascular diseases, and cancer, conditions which result from abnormalities to the vascular system.

Contact Information

ThromboGenics NV

Gaston Geenslaan 1
B-3001
Heverlee
Belgium
Phone: 32-16-75-13-10
Fax: 32-16-75-13-11

Key Executives for ThromboGenics NV (THR)

Gustaaf Van Reet "Staf"ChairmanPatrik De HaesCEO/Executive Director
Luc PhilipsInterim CFOKoen KasChief Scientific Officer
Laurence RaemdonckHead:Human ResourcesAndy De DeeneHead:Product Dev
David PearsonHead:Corporate DevAniz GirachHead:Clinical Dev
Paul De NijsHead:Market Access

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil